Reading regional AI adoption research: samples, denominators and task quality
Check units, sampling, stage definitions and follow-up before comparing regional or sector adoption rates. Separate cohort and conditional proportions, use and quality, and reported reasons and causal evidence before applying findings to a decision.
By
Tenten AI Delivery Team
Industry Delivery
Published
Updated
Read time
4 min

Before quoting how many AI projects go live, inspect the method. Procurement, pilots, production and use can have different definitions. Institutions, projects and users cannot share a denominator by assumption.
This guide supports comparison of adoption research, not a new Greater China market survey. The aim is to establish whether a finding supports procurement, budgeting or a next-stage decision rather than selecting the highest or lowest number.
Establish what was counted
An institution can have multiple projects and purposes; only some users may be eligible. Institution interviews do not automatically count projects, and self-reported use is not a record of every task.
AAPOR's disclosure standards identify population, recruitment, instruments, dates, samples, weighting, processing and limitations. The page identifies the relevant 2021 rules. This is a methodological reference, not Taiwan legal certification or evidence that this article conducted a survey.
| Comparison field | Locate in the source | Question if information is missing |
|---|---|---|
| Unit | Institution, project, purpose, user or task | Do numerator and denominator count the same unit? |
| Coverage | Region, sector, size and inclusion conditions | Which population does the finding describe? |
| Recruitment/sample | Selection, invitations, responses and exclusions | How might respondents differ from nonrespondents? |
| Collection | Questions, interviews and operating records | Are self-report and observation conflated? |
| Definitions/time | Deployment, use, quality and collection period | Is follow-up sufficient; did versions change? |
| Calculation | Denominators, weights, duplicates and stage relationships | Whole cohort or previous-stage conditional rate? |
| Missingness/exits | Unknown, paused, stopped and insufficient follow-up | Do exclusions alter the conclusion? |
| Sponsorship/limits | Researcher, funding and method limitations | Are methods and observations inspectable? |
Missing information remains a question; another attractive percentage cannot fill it.
Separate cohort and conditional proportions
This symbolic example describes calculation, not market or client results. Let N be projects in one cohort, P the projects in production, and U those production projects meeting a declared use definition.
P/N describes production across the cohort; U/N describes eligible use across the cohort; U/P describes use among production projects. The last requires U to be a subset of P, a nonzero P, and consistent periods and definitions. They answer different questions.
If a table reports U/N while prose says “among those deployed,” inspect the method or ask the author rather than choosing an interpretation. A study's frequency or follow-up rule is not a universal success threshold.
Keep use, quality and value separate
Logins, weekly use, task completion and correct outputs are different observations. Usage measures need eligible task opportunities; infrequent work may not suit daily-use criteria. Quality needs task-specific references, material errors, review and exception evidence.
Time and capacity comparisons also need case mix, corrections and full costs. Continued operation, clicks or citations do not establish safe, correct work or cash return. The NIST AI RMF supports contextual measurement and management, not regional rankings or fixed thresholds.
Check comparability across regions and sectors
Tasks, data, institutional size, dates, acceptance requirements and follow-up can differ. Compare these conditions before interpreting a gap. A higher sector rate alone does not establish better delivery.
Interview reasons help formulate questions; mention frequency is not causal importance. Technical quality, data, permissions, workflow, capacity and support may coexist. Standard products require task/configuration assessment rather than a conclusion that all are unsuitable.
Use studies to inform project evidence
Bring comparable findings, limitations and missing information back to the engagement. Decide what evaluation, approved data or scope adjustment is needed, including stopping unsuitable work. Intentional stopping is distinct from a failed release.
For an internal record, read the financial project-stage exercise. For usage and workload, use the healthcare evidence plan. Research supplies questions; project sources, owners and acceptance evidence support the next decision.
Summarize this page with AI
Related posts

Start with one workflow.
Agree on the next step.
Leave your contact details and question type. We will follow up by email to understand the work and discuss scope.